During the past decade, Onkologische Schwerpunktpraxis Dr. Schmidt conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkologische Schwerpunktpraxis Dr. Schmidt" #1 collaborator was "German CLL Study Group" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator, "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator and "University of Cologne" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Onkologische Schwerpunktpraxis Dr. Schmidt" are "Chronic Lymphocytic Leukemia" (5 trials), "Anemia" (1 trials), "Leukemia" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Onkologische Schwerpunktpraxis Dr. Schmidt" in a lesser frequency.

Most popular intervention types in "Onkologische Schwerpunktpraxis Dr. Schmidt" are "Drug" (9 trials), "Biological" (3 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fludarabine" (3 trials), "Rituximab" (3 trials), "Bendamustine" (2 trials), "Chlorambucil" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Onkologische Schwerpunktpraxis Dr. Schmidt" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Onkologische Schwerpunktpraxis Dr. Schmidt". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Onkologische Schwerpunktpraxis Dr. Schmidt, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Onkologische Schwerpunktpraxis Dr. Schmidt, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".